Colleen Mockbee Email

Chief Development Officer & SVP Regulatory . OncXerna

Current Roles

Employees:
11
Revenue:
$2.2M
About
Existing precision medicines target just 10 percent of cancers – those with gene mutations or oncogenic drivers for a small number of genes. Oncologie is ushering in a new era of precision medicine, leveraging the company's deep understanding of tumor biology at the RNA level to deliver more effective therapies for many more patients. OncXerna Therapeutics applies its understanding of RNA signatures to describe the dominant biology of the patient's cancer and match it to therapies with mechanisms that modify the dominant biology to dramatically improve patient outcomes.
OncXerna Address
Boston
Boston, MA
United States
OncXerna Email

Past Companies

Serafina Consulting, LLCPrincipal
OncXerna TherapeuticsChief Development Officer & SVP Regulatory
Eli Lilly and CompanyGlobal Product Development Leader, Verzenio

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.